Tom Winnifrith Bearcast No 1: The H2 Optibiotix cash burn, the prediction of when the money runs out and its funding options

I have been looking at the RNS of 17 February from Optibiotix (OPTI) again, doing some sums on just how bad H2 2025 was and pondering how close to a cash crisis are Steve O' Hara and the gang. I consider its funding options re Skinbiotherapeutics (SBTX), Probiotix (PBX) and raising fresh equity. It looks grim.

Read the full article